Proteomics in clinical trials and practice: present uses and future promise (Q33245305)

24 July 2017

1 reference

title

Proteomics in clinical trials and practice: present uses and future promise (English)

1 reference

24 July 2017

Nilofer S Azad

1

1 reference

24 July 2017

Nabila Rasool

2

1 reference

24 July 2017

Christina M Annunziata

3

1 reference

24 July 2017

Lori Minasian

4

1 reference

24 July 2017

Gordon Whiteley

5

1 reference

24 July 2017

Elise C Kohn

6

1 reference

24 July 2017

30 May 2006

1 reference

Molecular & Cellular Proteomics

24 July 2017

1 reference

24 July 2017

5

1 reference

24 July 2017

10

1 reference

24 July 2017

1819-1829

1 reference

Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry

24 July 2017

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Clinical proteomics: Applications for prostate cancer biomarker discovery and detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Proteomics: new perspectives, new biomedical opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Clinical cancer proteomics: promises and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Estrogen receptors as therapeutic targets in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Application of proteomics in the study of tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

SELDI-TOF-MS proteomics of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Mass spectrometry and protein analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Mass spectrometry-based clinical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Biomarkers of ovarian tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Serum proteomic patterns for detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Putative protein markers in the sera of men with prostatic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Autoantibody signatures in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Impact of proteomics on bladder cancer research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Biomarkers: mining the biofluid proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Identification of tumor-related proteins by proteomic analysis of cerebrospinal fluid from patients with primary brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Proteomic analysis of nipple aspirate fluid using SELDI-TOF-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Proteomic patterns of tumour subsets in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Protein profiles associated with survival in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Hypoxia-inducible transcription factor-1alpha promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Two proliferation-related proteins, TYMS and PGK1, could be new cytotoxic T lymphocyte-directed tumor-associated antigens of HLA-A2+ colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

The promise of genomics to identify novel therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

An efficient proteomics method to identify the cellular targets of protein kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Proteome-wide identification of cellular targets affected by bisindolylmaleimide-type protein kinase C inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Chemical proteomic analysis reveals alternative modes of action for pyrido[2,3-d]pyrimidine kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

The molecular make-up of a tumour: proteomics in cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chips

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Proteomics in acute myelogenous leukaemia (AML): methodological strategies and identification of protein targets for novel antileukaemic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Proteomic approaches in colon cancer: promising tools for new cancer markers and drug target discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Proteomics for hepatocellular carcinoma marker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Magnetic resonance image–guided proteomics of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Gene expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Single cell profiling of potentiated phospho-protein networks in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600008-MCP200

10.1074/MCP.R600008-MCP200

21 January 2018

Identifiers

DOI

1 reference

release_5mw2yrwkvfeuljpessskmxvtqm

24 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5mw2yrwkvfeuljpessskmxvtqm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference